These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15277618)

  • 1. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
    Silberstein SD; Elkind AH; Schreiber C; Keywood C
    Neurology; 2004 Jul; 63(2):261-9. PubMed ID: 15277618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebo-controlled, two-period crossover, single-centre study in healthy female volunteers.
    Wade A; Pawsey S; Whale H; Boyce M; Warrington S
    Clin Drug Investig; 2009; 29(5):325-37. PubMed ID: 19366274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
    Silberstein SD; Berner T; Tobin J; Xiang Q; Campbell JC
    Headache; 2009 Oct; 49(9):1283-97. PubMed ID: 19751371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.
    Mannix LK; Savani N; Landy S; Valade D; Shackelford S; Ames MH; Jones MW
    Headache; 2007; 47(7):1037-49. PubMed ID: 17635595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended cycle combined oral contraceptives and prophylactic frovatriptan during the hormone-free interval in women with menstrual-related migraines.
    Coffee AL; Sulak PJ; Hill AJ; Hansen DJ; Kuehl TJ; Clark JW
    J Womens Health (Larchmt); 2014 Apr; 23(4):310-7. PubMed ID: 24450487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frovatriptan as preemptive treatment for fasting-induced migraine.
    Latsko M; Silberstein S; Rosen N
    Headache; 2011 Mar; 51(3):369-374. PubMed ID: 21269298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks.
    Brandes JL; Poole Ac; Kallela M; Schreiber CP; MacGregor EA; Silberstein SD; Tobin J; Shaw R
    Cephalalgia; 2009 Nov; 29(11):1133-48. PubMed ID: 19811503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
    MacGregor EA; Pawsey SP; Campbell JC; Hu X
    Gend Med; 2010 Apr; 7(2):88-108. PubMed ID: 20435272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frovatriptan: a review of its use in the acute treatment of migraine.
    Sanford M
    CNS Drugs; 2012 Sep; 26(9):791-811. PubMed ID: 22900951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study.
    Newman L; Mannix LK; Landy S; Silberstein S; Lipton RB; Putnam DG; Watson C; Jöbsis M; Batenhorst A; O'Quinn S
    Headache; 2001 Mar; 41(3):248-56. PubMed ID: 11264684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan.
    Géraud G; Spierings EL; Keywood C
    Headache; 2002 Apr; 42 Suppl 2():S93-9. PubMed ID: 12028325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frovatriptan for the acute treatment of migraine: a dose-finding study.
    Goldstein J; Keywood C;
    Headache; 2002 Jan; 42(1):41-8. PubMed ID: 12005274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine.
    Balbisi EA
    Int J Clin Pract; 2004 Jul; 58(7):695-705. PubMed ID: 15311727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine.
    Brandes JL; Smith T; Diamond M; Ames MH
    Headache; 2007 Jun; 47(6):886-94. PubMed ID: 17578540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frovatriptan: pharmacological differences and clinical results.
    Rapoport AM
    Curr Med Res Opin; 2001; 17 Suppl 1():s68-70. PubMed ID: 12463282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menstrual migraine: timing is everything.
    Loder E
    Neurology; 2004 Jul; 63(2):202-3. PubMed ID: 15277607
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.
    Savi L; Omboni S; Lisotto C; Zanchin G; Ferrari MD; Zava D; Pinessi L
    J Headache Pain; 2011 Dec; 12(6):609-15. PubMed ID: 21842274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose range-finding studies with frovatriptan in the acute treatment of migraine.
    Rapoport A; Ryan R; Goldstein J; Keywood C
    Headache; 2002 Apr; 42 Suppl 2():S74-83. PubMed ID: 12028323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of frovatriptan: placebo-controlled studies.
    Ryan R; Géraud G; Goldstein J; Cady R; Keywood C
    Headache; 2002 Apr; 42 Suppl 2():S84-92. PubMed ID: 12028324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.